Anzeige
Mehr »
Donnerstag, 19.06.2025 - Börsentäglich über 12.000 News
+435 % Beteiligungsrendite durch TAO nach £5 Mio. Finanzierung und Bitcoin-Treasury-Strategie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
1.543 Leser
Artikel bewerten:
(0)

Atradius and Kemiex Launch First Online Trade Platform for Human and Animal Health and Nutrition Industries

AMSTERDAM, November 5, 2018 /PRNewswire/ --

Platform ensures trusted online trading and helps to identify sustainable trade partners

Atradius and Kemiex launch a digital trading platform for raw materials in the pharma, vet, food and feed industries. This new digital market place enables buyers and sellers of Active Pharmaceutical Ingredients (APIs) and additives to identify reliable trade partners and to trade safely. Atradius will offer support by providing credit risk insight and trade insurance for trade partners.

(Logo: https://mma.prnewswire.com/media/712156/Atradius_Logo.jpg )

The platform has been designed as an alternative for existing trading procedures that are often time consuming, prone to errors and might be limited to personal networks. Atradius and Kemiex also anticipate on the need in the human and animal health and nutrition industries to comply with strict regulations relating to quality control. Atradius contributes to the safety and transparency of the platform by providing a trade insurance for single transactions through one click on the Kemiex platform.

Global digital marketplace

The users of the platform are instantly connected with a worldwide network of qualified parties, enabling them to shorten the procedures for transactions, to agree on competitive prices and to remain in control during the process of trading. The main benefit is that buyers and sellers can do business with reliable parties that comply with relevant regulations and quality controls and are credit worthy. Kemiex estimates whether a company on the platform complies with quality standards, whereas Atradius analyses the credit worthiness of those acting on the platform. Together, they evaluate companies, their transactions and the behaviour of traders in order to ensure that transacting on the platform is as safe as possible.

Isidoro Unda, CEO of Atradius: "This strategic partnership is an excellent proof of our capabilities to create innovative solutions for our customers and develop new business around credit insurance. It is our responsibility to be at the forefront of digitalization and help our clients succeed in their global trade."

Pau Franquet, CEO of Kemiex: "Almost hundred early adopter companies from pharma, vet, food and feed industries are excited to use this unprecedented feedstock trading solution in their procurement or distribution units. While there are other matchmaking solutions for certain aspects of the sourcing process, we are confident to say that Kemiex is the first integrated online trading platform providing safe trading with reliable counterparties, worldwide."

The collaboration between Atradius and Kemiex is an important milestone in the use of the latest technology in order to provide customers with innovative solutions. Kemiex makes use of the latest trends in the field of digitization, connectivity, big data and social functions in order to offer users a new experience.

About Atradius
Atradius is a global provider of credit insurance, surety and collection services, with a strategic presence in over 50 countries. The credit insurance, bond and collection products offered by Atradius protect companies around the world against the default risks associated with selling goods and services on credit. Atradius is a member of Grupo Catalana Occidente (GCO.MC), one of the largest insurers in Spain and one of the largest credit insurers in the world. www.atradius.com

About Kemiex

Established in 2017, Swiss-based Kemiex is a premium trade network enabling safe and efficient trade through its pioneering online trading platform for buyers and sellers of active ingredients (APIs), additives and excipients in human and animal health and nutrition industries. Kemiex aims to deliver safe trading, with reliable counterparties, worldwide. www.kemiex.com

For further information please contact:
Atradius
Corporate Communications & Marketing
Olivier de Groot
Tel. +31 (0)20-553-2758
Mob. +31 (0)6-5183-7242
E-mail: olivier.de.groot@atradius.com

Connect with Atradius on Social Media
Website: https://group.atradius.com
LinkedIn: https://www.linkedin.com/company/atradius
Twitter: https://twitter.com/atradius
YouTube https://www.youtube.com/user/atradiusgroup

© 2018 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.